Black Rose Industries Limited (514183) Earnings Call Transcript & Summary

November 11, 2024

BSE Limited IN Industrials Trading Companies and Distributors earnings 22 min

Earnings Call Speaker Segments

Navin Agarwal

attendee
#1

Good afternoon, ladies and gentlemen, and thank you for attending this virtual meeting. It's my pleasure to welcome you on behalf of Black Rose Industries Limited and SKP Securities to this Q2 FY '25 financial results webinar. We have with us Mr. Ambarish Daga, Director, Joint CFO and IR Officer; and Mr. Bhavesh Shah, General Manager, Sales. This webinar is being recorded for compliance reasons, and during the discussion, there may be certain forward-looking statements. These must be viewed in conjunction with the risks that the company faces. We will have the opening remarks and a presentation by Mr. Daga, followed by a Q&A session. Thank you, and over to you, Ambarish.

Ambarish Daga

executive
#2

Thank you, Navin ji, and I extend a very warm welcome to one and all who's taken out time to attend this webinar. First of all, let me wish you all a very happy Diwali and a prosperous new year ahead. Now we can just start the presentation, Navin ji. While the presentation is uploaded, I would just like to put in a word of caution that there might be certain forward-looking statements in this presentation, and those may be viewed in conjunction with the risk the company faces. If you can just make it full screen, Navin ji. So as usual, we start off with the business presence of Black Rose. Black Rose started its journey into chemicals with the distribution of specialty and performance chemicals on the back of its strong relationships with its principals, which are based out of Japan, Germany and Thailand. This strong relationship helped us to graduate from being a chemical distributor, and we started manufacturing of chemicals when we set up South Asia's first acrylamide liquid plant back in 2013, in technical collaboration with Mitsui Chemicals of Japan. The initial capacity was 10,000 metric tons, whereas the current capacity stands at 32,000 metric tons per annum, of which 20,000 is marked for merchant sales and the balance is for our captive requirement. Going further down in the same chemistry, we also started manufacturing polyacrylamide liquids with a capacity of 40,000 metric tons and currently, this product goes into the binder application in the tile industry. Next, we also started with manufacturing n-methylol acrylamide with a capacity of 2,000 metric tons per annum. And currently, we are doing quite well in this particular product. Acrylamide solids was also started, which made us the only company outside of China to have the technology and to manufacture the acrylamide solids, and its currently installed capacity is 3,600 metric tons per annum. We are progressing well with the development of the polyacrylamide solid technology by our in-house R&D team and we are hopeful that by the end of this fiscal, as we mentioned earlier, we will be able to complete the R&D and start the onboard process. The initial plant capacity for this product is 10,000 metric tons per annum, and it should add substantially to our top line once it commercializes. B.R. Chemicals Company is the 100% subsidiary based in Japan and is engaged in the local as well as export of chemicals. The other legacy businesses add up to less than 1% of the total revenue for the company. Moving on to the next slide. We look at the snapshot of the financials. When we look at the profit and loss, we see that overall, there has been a growth in the revenue from operations on a stand-alone basis as well as on a consolidated basis. This has been on the back of very good performance in the distribution segment. You will see there's a dip shown in the consolidated figures, but I would like to highlight that this is only on account of the exclusion of INR 56 million of dividend distributed by the subsidiary, and it is as per the accounting standards. Overall, there has been steady progress in the EBITDA margin, the PAT margin, as well as the EPS for the company. Now moving on to the snapshot of the balance sheet. The company being in a stock and sale model in the distribution business, we have strategically increased our inventory, which has helped in the performance of the company. This is also reflected in the balance sheet snapshot. However, the company continues to remain a 0 long-term debt company, which is truly reflected in the very low debt-equity ratio and a healthy return on equity and capital employed. Now we move on to the next slide, where we talk about the segment-wise distribution of the financials for the previous quarter. We see that the chemical distribution business has grown at about -- sorry, Navin ji, it's the previous slide. Thank you. So when we look at the segment-wise performance, the chemical distribution business has grown on the top line by about 23%, while the chemical manufacturing business has grown by 32%. The higher sales volume and realization for the key distribution products such as resorcinol, ethanolamine and meta cresol are reflective of the higher turnover. In the manufacturing segment, we have picked up the market share in the local domestic market, which has led to the increase in the overall top line. This has been possible despite certain exports being unviable because of the logistics issues. Otherwise, the turnover would have actually been higher even in the manufacturing segment. Overall, we see there is a dip in the manufacturing segment margin, mainly because of the falling raw material prices, and in certain products, due to the dumping from China. This will be elaborated on in the subsequent slides. Next, we move on to the financials in terms of the revenue distribution and the domestic and export sales. So overall, because of the increase in the local share, we see that the percentage of exports has actually reduced from the previous quarter. However, overall, in terms of the volume, the exports were higher. That is how it is reflecting at 18% currently. In terms of the mix between manufacturing and distribution, again, in absolute terms, there is an increase in both the manufacturing as well as distribution. However, since the jump is much higher in the distribution business, that is reflective of the overall higher percentage of about 70%, which is coming from distribution. Now I will request Mr. Bhavesh to take you through the next couple of slides.

Bhavesh Shah

executive
#3

Thank you, Ambarish ji. Welcome, everybody, wishing everyone a Happy Diwali. If we come to the slide on our financials from the distribution segment. We can see, for this quarter, in distribution, we had a very strong support from our principals, which helped us in maintaining adequate stock levels and which helped us penetrate the local market with the demand, and we could supply to all the existing levels of demand, due to which our key products, they also added significantly to our top line along with the revenue. Volume also went up and revenue also went up. Our demand from the U.S. oil and gas sector for our merchant exports remained stable for the last quarter. And for the current quarter also, we expect slight improvement in that. The top 5 products of our company, the last quarter contributed around 88% to the top line, and it contributes about 86% of the profit. Next slide, please. If we talk about the financials from manufacturing. We can see in manufacturing, there has been an increase in sales for the manufacturing sector. Our local sales for AM liquid and NMA both were up. However, the realizations for AM liquid were basically down due to the declining in the raw material pricing. AM solid acrylic powder, again being impacted by the dumping from China, due to which volatile pricing, which is not helping the market, but we are trying to see, for the current quarter, with some normalization in the prices, we could achieve better sales. Our NMA sales are picking up significantly well because of higher lifting from our key customers. Our binder market in Morbi remained subdued mainly due to 3 reasons. First of all, there was increase in gas prices twice during the last quarter. They had a longer holiday period after Janmashtami, due to which lot of factories reopened after mid-September. And thirdly, because of the subdued export market. Towards the end of the last quarter, we have introduced a new robust version of our binder, for which we have received positive results till now. We expect this to increase our sales in the coming quarter. Now I hand it over again to Ambarish ji to take it forward.

Ambarish Daga

executive
#4

Thank you, Bhavesh ji. Now we look at the price trend of the key raw material and the realization from our acrylamide liquid. So as we see during the quarter, as Bhavesh ji also mentioned earlier, the raw material prices have been falling, which has put pressure on our product realization and also squeezed the total spread that we are able to achieve, which is also reflected in the slightly lower margin during this quarter. However, the prices have now stabilized. And in fact, if anything, have slightly gone up, which should help us in regaining this lost margins and also help us in better realization going forward. Moving on to the next slide. Now we look at the outlook for the current quarter. First, regarding the chemical distribution, as we mentioned, we are having a stock and sale kind of a model in the distribution business. And we are getting very strong support both in terms of material availability and pricing from our key principals. This is helping us in maintaining adequate stocks in serving the market's requirements and continuously gaining market share. It is going to continue this way, where we hope to have stable sales during this quarter as well. The domestic volumes, as I mentioned, will remain largely in the same direction. The merchant exports also seem to be picking up with the U.S. oil and gas demand coming back, which is also going to help us in increasing our sales volumes during this current quarter. The sales team is truly working on expanding its market share, and we expect to introduce some new products also during this quarter and the upcoming quarters. This will all help in overall increasing our distribution portfolio going forward. Moving on to the manufacturing side. First, we talk about the acrylamide liquid and solids. So as I mentioned, the prices of raw material have now stabilized. This will help us in increasing our market share further in the local market with the demand also stabilizing. At the same time, the international logistics situation seems to be improving during this quarter, and it will help us in expediting further exports and to increase our export volumes during this quarter. The acrylamide solid is likely to remain stable with the Chinese dumping being an inconsistent factor and the company is not very inclined to enter into an unfair pricing war as per its policy. Moving on to the polyacrylamide liquid. As we mentioned that despite the market remaining subdued, our new robust binder is getting good traction in the market. We are getting a very good response. And this is expected to help us in improving our sales volume for the ongoing quarter. At the same time, in n-methylol acrylamide, the consistency of the orders from key customers is going to make it a steady quarter for us. And this is a product that we are concentrating on to increase our market, as it also comes with very good margins for us. Moving on to the outlook for the ongoing and upcoming projects. So our R&D team has been strengthened over the time period, where we have mentioned earlier as well that we are having now one Japanese national who is already based in India in our R&D facility. And we also have our Japanese R&D consultants who are continuously coordinating with our team over here. This is helping us in moving fast towards finalization of the polyacrylamide solid. The new R&D facility work is now already underway, and we hope to complete the work by the end of this calendar year on the setup. We have also already identified the new land which we will be earmarking for future projects, keeping in mind that from our strong distribution relationships, we are actively seeking new opportunities to set up the manufacturing capacities for different products. In the same way, the EC application for the new specialty chemical project is also progressing well, and we hope to get the clearances in place at the earliest possible. I think that is all from me, Navin ji. And now you can please take it forward.

Ambarish Daga

executive
#5

Thank you, Ambarish. Thank you, Bhavesh. Friends, we now open the floor for the Q&A session. [Operator Instructions] We have a question from Shweta Agarwal.

Unknown Analyst

analyst
#6

This is Shweta from Triumph Worldwide Limited. I have a question. Ambarish ji said that on the ongoing projects, the land for 20 acres is for the future projects. So can you please elaborate more, means like this has been earmarked, like it is already there or you are going to purchase it? And how does it go about?

Ambarish Daga

executive
#7

Sure. Thank you for the question, Shweta. I will just explain in detail. So as I mentioned, the company has very strong relationships in its distribution business. And there are lots of companies which are keen to set up manufacturing facilities in India. And they look at Black Rose as one of the options, because of our strong relationships. Now land prices and availability of land is typically a challenge, and it often leads to delays in project viability and setup. So at this point of time, Black Rose is looking at acquiring a land and keeping the land ready, so that whenever the right opportunity comes for setting up a manufacturing unit, land availability is not going to be a challenge. So we don't have any project already identified for which this land parcel is being acquired. It is more like creating a land bank, so that future projects become more viable and are able to be implemented much faster. I hope that answers your question.

Unknown Analyst

analyst
#8

Yes.

Navin Agarwal

attendee
#9

[Operator Instructions] Since there are no further questions, I hand over the webinar back to Ambarish for his closing remarks. Friends, in case you do have some questions later on, my email ID is there or the invite. Request you to forward them. We'll take it up with the management. Thank you, and over to you, Ambarish.

Ambarish Daga

executive
#10

Thank you, Navin ji. I would just like to conclude the webinar by saying that the company is progressing well, and we are looking to maximize our sales as well as our profits in both the distribution as well as the manufacturing setup. Currently, the company is also looking at retaining its talent pool as well as acquiring new talent in order to further strengthen the company's efficiency and operations. So that is all from my side. And I hope to see you all soon in the next webinar at the end of the next quarter. Thank you very much.

Bhavesh Shah

executive
#11

Thank you.

Navin Agarwal

attendee
#12

On behalf of us at SKP Securities, thank you very much, Ambarish and Bhavesh for taking time out to interact with the investors. We look forward to hosting you again in the next quarter. Thank you, and have a wonderful day.

Ambarish Daga

executive
#13

Thank you.

For developers and AI pipelines

Programmatic access to Black Rose Industries Limited earnings transcripts and 32,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.